# FDA Inspection 1069249 - C.G. Laboratories, Inc. - September 26, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/cg-laboratories-inc/91e2d6ef-61ed-493b-b6b7-0638ba7257c5
Source feed: FDA_Inspections

> FDA Inspection 1069249 for C.G. Laboratories, Inc. on September 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069249
- Company Name: C.G. Laboratories, Inc.
- Inspection Date: 2018-09-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1276411 - 2025-07-24](https://www.globalkeysolutions.net/records/fda_inspections/cg-laboratories-inc/f24af4f5-8dec-459e-9b74-6ddb3403d6cd)
- [FDA Inspection 849946 - 2013-09-25](https://www.globalkeysolutions.net/records/fda_inspections/cg-laboratories-inc/874f6da4-3879-4198-9145-cb89cab80f52)
- [FDA Inspection 743272 - 2011-09-07](https://www.globalkeysolutions.net/records/fda_inspections/cg-laboratories-inc/555d1357-3834-47ac-9710-d1ba682b5259)

Company: https://www.globalkeysolutions.net/companies/cg-laboratories-inc/55779d6e-7db5-4ed5-8037-2b1d6ee69b6f

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d